News-Journal delivery questions RSS Feed Mobile Access
Register Now.  It's Free! Log In
Classifieds
Automotive
Real Estate
Employment
Merchandise
HEALTH
HealthDay | Archives

Unique Bone Marrow Transplant Said to Cure Sickle Cell

Unique Bone Marrow Transplant Said to Cure Sickle Cell

Related News from HealthDay
Guidelines Unveiled for Treating Clogged Heart Arteries
Many Turn Blind Eye to Racism
Inflammation Markers May Help Predict Stroke Risk
Studies Challenge Framingham Risk Score
Protein Might One Day Prevent Blindness
Doctors Urged to Screen Diabetics for Sleep Apnea
Health News Archives
   

FRIDAY, Nov. 14 (HealthDay News) -- A unique form of bone marrow transplantation is the only safe and effective cure for sickle cell disease, researchers at Children's Hospital of Pittsburgh report.

Traditional bone marrow transplants rely on heavy doses of chemotherapy prior to transplant in order to destroy a recipient's bone marrow so it won't reject the donated marrow. But that makes patients vulnerable to dangerous complications, something that's viewed as an unnecessary risk, because sickle cell disease typically isn't life-threatening, the researchers said.

This new transplant method relies on reduced intensity conditioning (RIC) regimens, which are less toxic to patients and eliminate life-threatening side effects generally associated with bone marrow transplantation. This means transplants can be offered to patients with severe sickle cell disease.

The researchers at Children's Hospital, part of the University of Pittsburgh Medical Center, reported that six of seven sickle cell patients who received RIC bone marrow transplants in the last decade now have donor marrow and are free of sickle cell disease symptoms.

The report was published in the November issue of the journal Biology of Blood and Marrow Transplantation.

"Bone marrow transplant is the only known cure for sickle cell disease. But doctors have avoided performing them in these patients, because complications from a traditional bone marrow transplant can be life-threatening," Dr. Lakshmanan Krishnamurti, a pediatric hematologist/oncologist and director of the Sickle Cell Program at Children's Hospital, said in a hospital news release. He helped develop RIC bone marrow transplants.

"Through the reduced-intensity approach we developed, the potential for complications is dramatically lessened. This study offers hope for a cure for thousands of patients with severe sickle cell disease," Krishnamurti said.

Sickle cell disease, an inherited blood disorder, affects about 80,000 people in the United States, primarily blacks. The disease can cause agonizing pain, strokes, damage to internal organs, and a shortened life expectancy.

More information

The March of Dimes has more about sickle cell disease.

 

Copyright © 2008 ScoutNews, LLC. All rights reserved.



HELPFUL TOOLS

Analyze Yourself

Calculate your body mass.
Analyze yourself for depression.
Rate yourself for thyroid disease.
Do you have a sinus infection?




Longview News-Journal Top Cars
GMC Yukon,5.3L V8 16V, Special Purpose Vehicle...(more) 
Dodge Grand Caravan,3.8L V6 12V produces a silky-smooth 215 hp at 5,000 RPM with 245 lbs. ft. of torque at 4,000 RPM with sequential multi-point fuel injection, Special Purpose Vehicle...(more) 
Jeep Liberty,3.7L V6 12V SOHC 210hp 235 lb-ft torque, Special Purpose Vehicle...(more) 
If you have any question please feel free to call 903-232-2573 or 1-800-657-5211 or me e mail @. rob.nystrom@phmc.us Thanks fo......(more) 
ASK FOR KURT HILL...(more) 
ASK FOR KURT HILL...(more) 
Infiniti G35,3.5L V6 24V DOHC CVTCS 280hp 270 ft-lb torque, Compact Car...(more) 
GMC Envoy,4.2L I6 MPFI DOHC, Special Purpose Vehicle...(more) 
-View All Top Cars-
-Place an Ad-
 

Longview News | Longview Weather | Sports | Features | Business News | Opinions | Classifieds | Sitemap
Longview Cars | Longview Real Estate | Longview Jobs

Copyright 2008 Longview News-Journal. All rights reserved.

By using this service, you accept the terms of our visitor agreement and privacy policy.
Registered site users, you may edit your profile.
Having trouble? Visit our help & FAQ